APA aipamena

Yang, F., Sun, S., Wang, C., Haas, M., Yeo, S., & Guan, J. (2020). Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation. Br J Cancer.

Chicago Style aipamena

Yang, Fuchun, Shaogang Sun, Chenran Wang, Michael Haas, Syn Yeo, and Jun-Lin Guan. "Targeted Therapy for MTORC1-driven Tumours Through HDAC Inhibition By Exploiting Innate Vulnerability of MTORC1 Hyper-activation." Br J Cancer 2020.

MLA aipamena

Yang, Fuchun, et al. "Targeted Therapy for MTORC1-driven Tumours Through HDAC Inhibition By Exploiting Innate Vulnerability of MTORC1 Hyper-activation." Br J Cancer 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.